shRNAs Can Identify T-Cell Inhibitory Mechanisms in Tumor Microenvironment

Get Permission

Although recent findings indicate that targeting of inhibitory receptors on T cells can produce durable responses in some cancer patients despite the presence of advanced disease, the mechanisms controlling T-cell function in immunosuppressive tumors have not been well characterized. In a study reported in Nature, Zhou and colleagues showed that it is possible to systemically identify these inhibitory mechanisms in the tumor microenvironment.

The investigators constructed a pooled short hairpin RNA (shRNA) screen in which shRNAs targeting negative regulators become highly enriched in murine tumors after releasing a block on T-cell proliferation in response to tumor antigen recognition in vitro. The shRNAs were identified by deep sequencing of the shRNA cassette from T cells infiltrating tumor or control tissues. One of the target genes identified was Ppp2r2d, a regulatory subunit of the PP2A phosphatase family. Ppp2r2d knockdown in tumors reduced T-cell apoptosis and increased both T-cell proliferation and cytokine production.

The investigators concluded, “Key regulators of immune function can … be discovered in relevant tissue microenvironments.” ■

Zhou P, et al: Nature 506:52-57, 2014.




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.